PA

Pondahavakkam Arunodayan Priya

Active Director Director DIN 06686026
DIN 06686026 First appointment Oct 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Oct 2013
Shareholding value •••• Premium profile

About Pondahavakkam Arunodayan Priya

Data last updated:

Pondahavakkam Arunodayan Priya is a Director at Hubra Pharmaceuticals Private Limited (since 2016), Director at 3G Surgical Industries Private Limited (since 2019) and Director at Mokksha Management Services Private Limited (since 2013). The companies operate in Pharma, Healthcare and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹18.20 Cr; the largest is Hubra Pharmaceuticals Private Limited at ₹13.56 Cr (FY 2024).

DIN 06686026
Primary Designation Director
Industry Pharma
First Appointment 17 Oct 2013
Oldest Company Age 13 yrs
Largest company Hubra Pharmaceuticals Private Limited · ₹13.56 Cr (FY 2024)
Combined revenue ₹18.20 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Mar 20162016₹13.56 Cr (FY 2024)Active
Director08 Jan 20192019₹2.83 Cr (FY 2024)Active
Director17 Oct 20132013₹1.81 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Hubra Pharmaceuticals Private Limited
3G Surgical Industries Private Limited
Mokksha Management Services Private Limited
Premium access

Shareholding and investment profile for Pondahavakkam Arunodayan Priya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pondahavakkam Arunodayan Priya

Pondahavakkam Arunodayan Priya currently holds 3 directorships: Hubra Pharmaceuticals Private Limited (Director, since 17 Mar 2016, revenue ₹13.56 Cr (FY 2024)); 3G Surgical Industries Private Limited (Director, since 08 Jan 2019, revenue ₹2.83 Cr (FY 2024)); Mokksha Management Services Private Limited (Director, since 17 Oct 2013, revenue ₹1.81 Cr (FY 2024)).

Pondahavakkam Arunodayan Priya was first appointed on 17 Oct 2013 as Director at Mokksha Management Services Private Limited. The most recent appointment on record is 08 Jan 2019 at 3G Surgical Industries Private Limited.

The 3 current companies of Pondahavakkam Arunodayan Priya that report revenue have a combined latest revenue of ₹18.20 Cr: Hubra Pharmaceuticals Private Limited ₹13.56 Cr (FY 2024); 3G Surgical Industries Private Limited ₹2.83 Cr (FY 2024); Mokksha Management Services Private Limited ₹1.81 Cr (FY 2024).

The current boards of Pondahavakkam Arunodayan Priya's companies include Pondavakkam Arunagirinathan Arunodhayan (Hubra Pharmaceuticals Private Limited), Pondavakkam Vijaya Arunagirinathan (Hubra Pharmaceuticals Private Limited), Pondavakkam Ananthakrishnan Karthick (3G Surgical Industries Private Limited), Pondavakkam Ayyappan Kokila (3G Surgical Industries Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available